Table 2.
ST | ESBL bla |
Carb R bla |
Intrinsic β-Lactamase bla |
Virulence |
---|---|---|---|---|
101 (6) | CTX-M-15 (6) | NDM-1 (1); ompK substitution (1) | SHV-1 | ybt9 (6) |
11 (1) | CTX-M-15 | NDM-4 | SHV-11 | ybt9 |
1198 (1) | - | - | SHV-11 | |
13 (1) | CTX-M-15 | - | SHV-1 | |
1147 (1) | - | - | SHV-27 | |
147 (9) | CTX-M-15 (9) | NDM-1 (5); NDM-5 (1) | SHV-11 | ybt9 (6) |
ST15 (6) | CTX-M-15 (5) | OmpK35 substitution (1) | SHV-28 | ybt9 (1) |
ST17 (4) | CTX-M-15 (2) | NDM-1 | SHV-11 | |
ST20 (7) | CTX-M-15 (7) | NDM-1 (5) | SHV-187 | |
ST218-3LV | - | - | SHV-93 | |
ST219 (2) | CTX-M-15 (2) | - | SHV-1 | |
ST231 (2) | CTX-M-15 (1) | OXA-232 (1) | SHV-1 | ybt14 (1); iuc (1) |
ST237 (2) | - | - | SHV-11 | |
ST24-1LV | - | - | SHV-11 | |
ST2459 (1) | CTX-M-15 | - | SHV-1 | |
ST2674 (1) | CTX-M-15 | NDM-1 | SHV-11 | |
ST2735 (1) | - | - | SHV-11 | |
ST29-1LV (1) | CTX-M-15 | - | - | |
ST292 (1) | CTX-M-15 | - | SHV-11 | |
ST307 (6) | CTX-M-15 (6) | NDM-1 (4) | SHV-28 | ybt10 (3) |
ST3161 (1) | - | - | SHV-11 | |
ST3430 (1) | CTX-M-15 | - | SHV-77 | |
ST38 (1) | CTX-M-15 | NDM-1 | SHV-11 | |
ST383 (5) | CTX-M-14 (4);CTX-M-15 (4) | NDM-5 (4); OXA-48 (4) | SHV-1 | iuc1 (4); rmp1 (2) |
ST39 (1) | - | - | SHV-1 | ybt4 |
ST437 (7) | CTX-M-15 (7) | NDM-1 (1); NDM-5 (6) | SHV-11 | ybt9 (7) |
ST45 (1) | CTX-M-15 | OmpK36 variant | SHV-1 | ybt10 |
ST469 (1) | CTX-M-15 | - | SHV-11 | |
ST474 (1) | CTX-M-15 | - | SHV-11 | |
ST501 (1) | CTX-M-15 | - | SHV-11 | |
ST514 (1) | CTX-M-15 | - | SHV-63 | |
ST530 (2) | CTX-M-15 (2) | NDM-1 (2) | - | ybt10 (2) |
ST664 (2) | CTM-X-15 (2) | NDM-1 (2) | SHV-11 | |
ST882 (2) | - | - | - | ybt (2) |
ST901 (1) | CTX-M-15 | - | SHV-1 |
ST: sequence type; ESBL: extended-spectrum β lactamase; Carb: carbapanemase; OmpK: outer-membrane porin substitutions contributing to carbapenem resistance; ybt: Yersiniabectin; Numbers in brackets indicate the number of isolates. Table S1 contains details of each isolate.